Adjuvant Radiotherapy or ET Lowers Locoregional Recurrence Rates Risk in Early-Stage Breast Cancer: JAMA
USA: Researchers have found in a new study that adjuvant radiotherapy (RT) or endocrine therapy (ET) significantly reduces the risk of locoregional recurrence (LRR) in patients with early-stage breast cancer and low genomic risk. The findings, published in JAMA Network Open by David Gibbes Miller from the Department of Radiation Oncology, Memorial Sloan Kettering Cancer […]